More Globe Newswire

View Older Stories View Newer Stories

Nov 12, 2024 07:30AM Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results
Nov 12, 2024 07:30AM Chart Industries Hosts 2024 Capital Markets Day
Nov 12, 2024 07:30AM Incyclix Bio Expands Board of Directors with Appointment of Norman E. Sharpless, MD
Nov 12, 2024 07:29AM BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million
Nov 12, 2024 07:24AM Bybit Posts Remarkable Volume Surge, Exceeding 639 Billion in Monthly Futures Trading Volume
Nov 12, 2024 07:21AM Business trends: Yat Siu, Founder and Executive Chairman of Animoca Brands - The Future of Hong Kong Web3 Lies in Building a Sustainable Digital Asset Environment
Nov 12, 2024 07:20AM Eika Boligkreditt AS: Report for the third quarter 2024
Nov 12, 2024 07:17AM Howard Hughes Holdings Appoints Jose Bustamante as President of Nevada Region
Nov 12, 2024 07:15AM Draganfly to Host Shareholder Update and Q3 Earnings Call
Nov 12, 2024 07:12AM Micron Introduces World’s Fastest, Most Energy Efficient 60TB SSD
Nov 12, 2024 07:10AM Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results
Nov 12, 2024 07:10AM Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Nov 12, 2024 07:10AM Jeito Capital co-leads €164.5 million ($181.4 million) oversubscribed Series D financing in Alentis Therapeutics to advance clinical development of Anti-Claudin-1 ADCs in solid tumors
Nov 12, 2024 07:06AM MT Højgaard Holding A/S: MT Højgaard Holding upgrades outlook for 2024
Nov 12, 2024 07:05AM IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights
Nov 12, 2024 07:05AM Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences
Nov 12, 2024 07:05AM Cherry T. Thomas, M.D., Joins Wugen as Chief Medical Officer, Bringing Cell Therapy Expertise Across Clinical Development, Regulatory, and Medical Affairs as the Company Embarks on a Pivotal Trial for
Nov 12, 2024 07:05AM Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
Nov 12, 2024 07:00AM Nevada Lithium Significantly Increases the Size and Grade of Lower Zone Inferred Mineral Resources at Bonnie Claire to 25.634 Mt LCE at 3,085 ppm Li. Reports Maiden Indicated Resources of 5.167 Mt LCE
Nov 12, 2024 07:00AM HPQ Silica Polvere Fumed Silica Reactor Project Update
Nov 12, 2024 07:01AM Prospect Capital Management Partners with iCapital to Expand Investment Advisor Access to Closed End Fund (CEF) and Business Development Company (BDC) Opportunities
Nov 12, 2024 07:00AM Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
Nov 12, 2024 07:00AM Experience the Ultimate 420 Festival Celebration with SweetWater's 20th Anniversary Lineup Featuring The Revivalists, Marcus King Band, Greensky Bluegrass, Drive-By Truckers and Cypress Hill at A
Nov 12, 2024 07:00AM Shoals Technologies Group, Inc. Reports Financial Results for Third Quarter 2024
Nov 12, 2024 07:00AM Opthea’s Wet AMD Program Featured at Ophthalmology Events
Nov 12, 2024 07:00AM Churchill Resources Announces Fully Subscribed $2M Private Placement
Nov 12, 2024 07:00AM Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results
Nov 12, 2024 07:00AM Kura Sushi USA Announces Pricing of Public Offering of Common Stock
Nov 12, 2024 07:00AM InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update
Nov 12, 2024 07:00AM KOL Collaborators Present Microbix HPV Test-Control Results
Nov 12, 2024 07:00AM BioXcel Therapeutics Advances Pivotal Phase 3 Trials of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders, Schizophrenia, and Alzheimer’s Dementia
Nov 12, 2024 07:01AM Prospect Capital Corporation to Present at the 2024 Markets Group NYC Private Credit Conference
Nov 12, 2024 07:00AM Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update
Nov 12, 2024 07:00AM GHD awarded major federal contract to support Canada’s net-zero fleet goals
Nov 12, 2024 07:00AM Creative Realities to Participate in Upcoming Craig-Hallum Conference
Nov 12, 2024 07:00AM ATC, an AI-themed Meme Coin, Will Be Listed on CoinW Exchange
Nov 12, 2024 07:00AM Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Nov 12, 2024 07:00AM IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting
Nov 12, 2024 07:00AM Altimmune Announces Third Quarter 2024 Financial Results and Provides a Business Update
Nov 12, 2024 07:00AM Spineart Announces the Opening of the Spineart Innovation Center in Dallas, Texas
Nov 12, 2024 07:00AM 4 in 5 Canadians say homeownership is now a luxury as new survey reveals impact of the housing crisis on quality of life
Nov 12, 2024 07:00AM U.S. Energy Corp. Reports Financial and Operating Results for Third Quarter 2024
Nov 12, 2024 07:00AM Krystal Biotech to Present at Stifel 2024 Healthcare Conference
Nov 12, 2024 07:00AM Nusano to Present at William Blair Virtual Radiopharmaceuticals Event
Nov 12, 2024 07:00AM CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Nov 12, 2024 07:00AM Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Nov 12, 2024 07:00AM H&R Block’s 2024 Outlook on American Life Report Reveals Most American’s Income Is Outpacing Inflation But Debt Threatens Future Prosperity
Nov 12, 2024 07:00AM Wugen to Initiate a Pivotal Trial for Its Investigational, Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy, WU-CART-007, in Patients with Relapsed or Refractory T Cell Acute Lymphoblastic L
Nov 12, 2024 07:00AM Vantage Hemp Co. Announces Commercial Launch of CBG Isolate and Significant Regulatory Developments
Nov 12, 2024 07:00AM Dragonfly Energy and Bruker Partner to Accelerate Battery Technology Development
View Newer Stories View Older Stories